DIGAMI in a district general hospital in the UK
Bhattacharyya A, Vice PA
The mortality and morbidity in diabetic in diabetic patients with AMI is higher than in non – diabetic population (2). The proven benefit of a number of interventions (Aspirin, betablocker, thrombolysis, ACE inhibitor, etc) for the acute event implies a major advantage in terms of absolute gain in life expectancy. The DIGAMI study has shown a major advantage of improved glycaemic control, so much so that we need to treat only nine patients to save one life in the line of DIGAMI treatment protocols. We evaluated the impact of the DIGAMI study in our hospital and compared the morality and other outcomes for an 18 month period after the DIGAMI study was published, in comparison to an 18 months period before.
Diabetes Today 2000;3:120-23.
We are at home for quite sometime now due to Covid 19 pandemic, trying our…
What is Trans fat? Trans fat is considered the worst type of fat we can…
As per the current practice in INDIA, when you are positive you will be in…
Red Bell Peppers Use bright bell peppers in Indian or continental cuisines to keep your…
What are sex hormones? Hormones which are secreted by the testis in males and ovaries…
How does Obesity worsen the general condition? Obesity is one of the major risk factors…